| Source publication date | |
|---|---|
| Reported on Testosterone Science | |
| Outlet type | Testosterone and hormone clinic or telehealth website |
| Population | Men |
| Source | Stacker (Hone Health) |
| URL | stacker.com/stories/mens-health/new-data-suggests-hormones-play-bigger-role-mens-mental-health-thought (opens in a new tab) |
Specific Claim Evaluated
Among 3,239 men with low testosterone treated with testosterone, 83% of those with moderate depressive symptoms had a clinically meaningful improvement within 12 months, with mean PHQ-9 scores falling from 11.7 to 3.9.
Primary Research Supporting or Contradicting the Claim
In TRAVERSE, a randomized, placebo-controlled trial in 5,204 men with hypogonadism, testosterone was associated with small improvements in mood and energy compared with placebo, and showed no significant benefit in men with rigorously defined low-grade persistent depressive disorder (Bhasin et al., 2024). Guidelines recommend against routine screening of men for hypogonadism (Bhasin et al., 2018).
Corrected Evidence-Based Interpretation
Randomized evidence shows that testosterone produces a small improvement in depressive symptoms in men with confirmed hypogonadism. Uncontrolled improvements in patients of a single telehealth provider cannot be attributed to testosterone.
Rationale for Grade
The article includes a clinician's caveat, but its headline and lead present uncontrolled, provider-collected patient data as new evidence of a larger hormonal role in mental health. Without a placebo group, regression to the mean, concurrent care and selective follow-up cannot be excluded, and the effect size is far larger than in randomized trials. The publisher sells the therapy evaluated.
References
- Bhasin S, Brito JP, Cunningham GR, Hayes FJ, Hodis HN, Matsumoto AM, Snyder PJ, Swerdloff RS, Wu FC, Yialamas MA. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. PMID
Supporting excerpt: "We recommend making a diagnosis of hypogonadism only in men with symptoms and signs" - Bhasin S, Seidman S, Travison TG, Pencina KM, Lincoff AM, Nissen SE, Miller MG, Flevaris P, Li X, Wannemuehler KA, Pope HG. Depressive syndromes in men with hypogonadism in the TRAVERSE trial: response to testosterone-replacement therapy. J Clin Endocrinol Metab. 2024;109(7):1814-1826. PMID
Supporting excerpt: "TRT is associated with small improvements in mood and energy"